Evidence map›Paper›PMID 42691425›Full record

Trial reportJMIR formative research2026

Applying an AI Decision Support Device During Cervical Cancer Screening in Bangladesh and Uganda: Implementation Study.

Jaap Koot, Johnblack Kabukye, Guruvare Shyamala, Naheed Nazrul, Aminur Rahman Shaheen, Carolyn Nakisige, Shamim Namagembe, Keerthana Prasad, Jogchum Beltman

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05234112 (Prevention and Screening Intervention Project - Towards Elimination of Cervical Cancer), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05234112 nacompletednot on this map

Prevention and Screening Intervention Project - Towards Elimination of Cervical Cancer

TypeinterventionalSponsorUniversity Medical Center GroningenRan2022 to 2024Enrolled30,000ConditionsHPV Infection, Cervix Cancer, Cervical DysplasiaArmsCommunity mobilisation for hrHPV self-testing, hrHPV self-testing, Follow-up after testing, VIA, Thermo-ablation or cryotherapy for dysplasia
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jaap KootGlobal Health Unit, Department of Health Science, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713 GZ, The Netherlands, 31 622487689.ORCID 0000-0002-6933-0302
Johnblack KabukyeUganda Cancer Institute, Kampala, Uganda.ORCID 0000-0002-7864-1858
Guruvare ShyamalaDepartment of Gynecology and Obstetrics, Manipal Academy of Higher Education, Kasturba Medical College, Manipal, Manipal, India.ORCID 0000-0001-7933-2400
Naheed NazrulFriendship, Dhaka, Bangladesh.ORCID 0000-0003-3906-3490
Aminur Rahman ShaheenHealth Systems and Population Studies Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.ORCID 0000-0003-1434-3883
Carolyn NakisigeUganda Cancer Institute, Kampala, Uganda.ORCID 0000-0002-1497-8056
Shamim NamagembeUganda Rural Development and Training Program, Kigadi, Uganda.ORCID 0009-0003-3626-2053
Keerthana PrasadManipal School of Information Sciences, Manipal Academy of Higher Education, Manipal, India.ORCID 0000-0002-4138-6814
Jogchum BeltmanDepartment of Obstetrics and Gynaecology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-0048-7360

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Screening is important for early detection of cervical cancer in low- and middle-income countries. Visual inspection with acetic acid (VIA) is usually the method of choice in these settings. However, interpretation of VIA results is subject to interobserver and intraobserver variability. AI decision support systems (AI-DSSs) could contribute to better decisions by health workers. Objective: The aim of this study was to analyze the barriers and facilitators of introducing an AI-DSS device under field conditions in the context of VIA screening in rural Bangladesh and Uganda, with the goal of improving the operational systems of applying an AI-DSS device. Methods: We operationalized the Consolidated Framework for Implementation Research for this specific study and defined the constructs for analysis. The study was performed in rural Uganda and Bangladesh. We extracted relevant information from routine data, patient surveys, and facility surveys. We also interviewed health workers who used the AI-DSS devices. A panel of experts performed an analysis of the quality of pictures and the performance of health workers. We monitored implementation through quarterly meetings and documented the process. This trial was registered under ClinicalTrials.gov identifier NCT05234112. Results: The applied AI-DSS passed tests under laboratory conditions but performed less well under field conditions. The hardware design using an adapted mobile phone was adequate, and the user interface was user-friendly and intuitive. However, operating the device while performing VIA in clinics was challenging. Since the device was not registered as a medical device, it was only used for research purposes. In both countries, there was no official government policy concerning the use of AI in health care. All facilities had gynecological examination rooms, but some facilities did not have permanent electricity or internet connection. The normal procedure for VIA was followed, and AI-DSS did not interfere with routine screening procedures. The AI-DSS was well accepted by women when privacy was guaranteed, but there seemed to be more trust in the judgment of health workers. The pictures helped supervisors to give a second opinion from a distance and were used for training purposes. The technical support team was able to help remotely and improved the performance. Training health workers in taking good pictures was very important. A permanent monitoring process during implementation was established, which led to early detection and correction of shortfalls. Conclusions: According to this study, the device has the potential for improving the quality of the assessment by health workers who perform VIA. However, competent staff trained in performing VIA will be indispensable for capturing high-quality pictures. The algorithm requires further fine-tuning. This study showed that the Consolidated Framework for Implementation Research is a proper tool for categorizing barriers and facilitators when introducing an AI-DSS device in practice.

Indexed as

Artificial IntelligenceEarly Detection of CancerMass ScreeningUterine Cervical NeoplasmsBangladeshFemaleHumansSurveys and QuestionnairesUgandaartificial intelligencebarriers and facilitatorscervical cancer screeningCFIRConsolidated Framework for Implementation Researchdeviceimplementationvisual inspection

Identifiers

PMID42691425
PMCPMC13541229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.